Angel Investor
Siddhant Jayakumar has been an angel investor in the following startups:
Sable Bio secures £1.5 million funding to revolutionize drug target safety evaluation with their AI-enhanced platform, offering substantial cost and time savings in drug development, ultimately delivering safer drugs to patients faster.
Siddhant Jayakumar is an angel investor based in Cambridge, in the UK.
Angel Investors